Abstract
The New York State Department of Health (NYSDOH) AIDS Institute (AI) began an initiative in 1990 in collaboration with the Office of Alcoholism and Substance Abuse Services (OASAS) to colocate HIV prevention and clinical services at drug treatment clinics. In 1990, the initiative began funding drug treatment programs to provide HIV counseling, testing, and prevention services. HIV primary care was added the following year. Program implementation and development are described. An analysis is included of HIV counseling and testing data for the period 1990–2002 and quality of care data for five standardized quality measures with comparisons to data from other clinical settings. In the first 13 years of the initiative 168,340 HIV-antibody tests were conducted including 52,562 tests of injection drug users (IDUs) identifying 14,612 HIV-infected persons; the seroprevalence was 8.68%. By the end of 2000, the HIV primary care caseload peaked at 3,815 patients. Quality of primary medical care services among participating drug treatment programs has consistently matched or exceeded that provided in more conventional health care settings such as the hospitals and community health centers that were used as a basis for comparison. Colocating HIV primary care within substance use treatment is an effective strategy for providing accessible high-quality HIV prevention and primary care services.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AIDS In New York State; 2001–2002. New York State Department of Health. Available at: http://www.nyhealth.gov/diseases/aids/reports/homeaids.htm. Accessed on: September 26, 2006.
Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in NYC, 1991–1996. Am J Public Health. 1998;88:1801–1806.
Stone VE, Weissman JS, Cleary PD. Satisfaction with ambulatory care of persons with AIDS: predictions of patient ratings of quality. JGIM. 1995:10;239–245.
Substance Abuse and Mental Health Services Administration (SAMHSA). Available at: http://oas.samhsa.gov/tx.htm, click on “State Data”. Accessed on: September 26, 2006.
OASAS-Certified Treatment System. Available at: http://www.oasas.state.ny.us. Accessed on: September 26, 2006.
Schlenger WE, Kroutil LA, Roland EJ. Case management as a mechanism for linking drug abuse treatment and primary care: preliminary evidence from the ADAMHA/HRSA linkage demonstration. NIDA Research Monograph. 1992;(127).
Yedidia MJ, Hanson KL. Integrating HIV-Related Primary Care and Drug Treatment: Lessons from New York State. APPJ. Fall 2003;7(3).
Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of On-Site Primary Care Services by HIV-Seropositive and Seronegative Drug Users in a Methadone Maintenance Program. Public Health Rep. July–August 1993;108(4):492–500.
Selwyn PA. The impact of HIV infection on medical services in drug abuse treatment programs. JSAT. 1996;13(5):397–410.
AIDS Institute Clinical Education Initiative. Available at: http://www.hivguidelines.org. Accessed on: September 26, 2006.
HIV Quality of Care Initiative. Available at: http://www.hivguidelines.org. Accessed on: September 26, 2006.
Heiner KW, Walshaw D. “Inferences on Healthcare Indicators for the Treatment of HIV/AIDS”. Eurostat. 2001;213–222.
Heiner KW, Laws D, Walshaw D. “Simulation in Models of Health Care Quality”. Computing Science and Statistics. 2000;32.
Centers for Disease Control and Prevention. HIV Prevalence Trends in Selected Populations in the United States: Results from National Serosurveillance, 1993-1997. Atlanta: Centers for Disease Control and Prevention;2001:1–51. Available at: http://www.cdc.gov/hiv/pubs/hivprevalence/hivprevalence.htm. Accessed on: October 5, 2006.
Department of Health and Human Services Cases of HIV Infection and AIDS in the United States, 2004. Commentary Section. February 28, 2006.
Report on Syringe Access in New York State; January 2005. New York State AIDS Advisory Council. Available at: http://www.health.state.ny.us/diseases/aids/workgroups/aac/docs/syringeaccess.pdf Accessed on: October 6, 2006.
Data reports produced by The New York State Office of Alcoholism and Substance Abuse Services (OASAS) Research Division. June 1, 2006.
Guderman DM, Carter WC, Charuvastra VC, Ling W. Clinical Utility of Screening Laboratories in the Initiation of Methadone Treatment. 28th Annual Medical Scientific Conference. April, 1997.
Umbrecht-Schneiter A, Ginn D. Providing medical care to methadone clinic patients: referral va on-site care. Am J Public Health. 1994;84(2):207–210.
Acknowledgments
The authors wish to express their gratitude to, Humberto Cruz, Alma Candelas, Daniel O’Connell, Roberta Glaros, Mona Scully, and Megan Tesoriero for their contributions in the creation, development, and implementation of the HIV and drug treatment Colocated Initiative.
Author information
Authors and Affiliations
Corresponding author
Additional information
Rothman is with the Bureau of HIV Ambulatory Care, AIDS Institute, New York State Department of Health, Albany, New York, USA; Rudnick and Slifer are with the Substance Abuse Unit, AIDS Institute, New York, NY, USA; Agins is with the Office of the Medical Director, AIDS Institute, New York, NY, USA; Heiner is with the Karl Heiner Statistical Consulting, Ltd., Schenectady, New York, USA; Birkhead is with the AIDS Institute, Albany, New York, USA.
Rights and permissions
About this article
Cite this article
Rothman, J., Rudnick, D., Slifer, M. et al. Co-located Substance Use Treatment and HIV Prevention and Primary Care Services, New York State, 1990–2002: A Model for Effective Service Delivery to a High-Risk Population. J Urban Health 84, 226–242 (2007). https://doi.org/10.1007/s11524-006-9137-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11524-006-9137-3